ISSN:

Journal Home

Translational Oncology Q1 Unclaimed

Neoplasia Press, Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Translational Oncology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 78. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2070 €. The scope of the journal is focused on translational oncology, cancer, genetics, endocrinology, tumour. It has an SJR impact factor of 1,408 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,408.

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Oncology (Q1) Cancer Research (Q2)

Price

2070 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,408

SJR Impact factor

78

H Index

352

Total Docs (Last Year)

883

Total Docs (3 years)

19257

Total Refs

4280

Total Cites (3 years)

864

Citable Docs (3 years)

4.18

Cites/Doc (2 years)

54.71

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular Cancer Q1
JAMA oncology Q1
Journal of Thoracic Oncology Q1
Cancer Discovery Q1
Neuro-Oncology Q1

Compare this journals

Aims and Scope

Translational oncology Cancer Genetics Endocrinology Tumour